DexCom Inc
(NAS:DXCM)
$
80.47
1.06 (1.33%)
Market Cap: 31.02 Bil
Enterprise Value: 30.73 Bil
PE Ratio: 47.55
PB Ratio: 15.66
GF Score: 81/100 Dexcom Inc at Wells Fargo Healthcare Conference Transcript
Sep 07, 2022 / 06:35PM GMT
Release Date Price:
$88.37
(+7.73%)
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo, and it's my pleasure to host this session with Dexcom. With us, we have Jereme Sylvain, Executive Vice President and CFO; and Matt Carey of Investor Relations. In terms of format, it's going to be a fireside chat. If anyone has a question they want to ask, just raise your hand, and we'll call on you. Jereme, thanks so much for being here.
Jereme M. Sylvain
DexCom, Inc. - Executive VP, CFO & CAO
Thanks for having us, Larry. Thanks, everyone, for joining us today. It's good to see so many faces.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So we've been starting with the macro environment and even though the macro environment hasn't affected you that much, Dexcom that much, you still have had some
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot